Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Advanced Materials (Deerfield Beach, Fla.)|December 28, 2022
Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of CancerFangmin Chen, Tianliang Li, Huijuan Zhang, et al.Journal of Medicinal Chemistry|March 7, 2023
Discovery of 2<i>H</i>-Indazole-3-carboxamide Derivatives as Novel Potent Prostanoid EP4 Receptor Antagonists for Colorectal Cancer ImmunotherapyZhiyuan Cheng, Yijie Wang, Yao Zhang, et al.Cell Death & Disease|March 24, 2017
Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogsJiancheng Zhou, Eun-Jin Yun, Wei Chen, et al.BMC Cancer|May 26, 2023
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growthYihua Lin, Yiling Zhao, Minggui Chen, et al.Oncotarget|July 30, 2016
Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analoguesWei Chen, Jiancheng Zhou, Kaijie Wu, et al.Chemical Science|June 9, 2023
Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growthChunyong Ding, Mengyan Du, Zhi Xiong, et al.Nature Communications|September 18, 2014
Small-molecule Bax agonists for cancer therapyMeiguo Xin, Rui Li, Maohua Xie, et al.Cancer Cell|May 26, 2015
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer TherapyBingshe Han, Dongkyoo Park, Rui Li, et al.Cancer Research|April 7, 2017
Modulation of Bax and mTOR for Cancer TherapeuticsRui Li, Chunyong Ding, Jun Zhang, et al.Cancer Cell|August 8, 2025
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancersJuanjuan Feng, Xuanzheng Xiao, Xinting Xia, et al.Pageof 9